OUTSOURCE! belongs to the Contract Laboratory Network
Advertisement
Integrated DNA Technologies (IDT) has introduced the xGen Hybridization and Wash v3 Kit, a powerful new tool designed to meet the performance and turnaround demands of contract testing laboratories supporting oncology research. Debuted ahead of the AACR 2025 Annual...
Unlocking Enhanced Sensitivity and Precision for Contract Labs in Cancer Biomarker Research
With FDA approval and unique PLA code, oncoReveal™ CDx supports actionable cancer diagnostics for contract labs
There are several methods for analyzing DNA methylation, each with its advantages, limitations, and applications.
The field of biotheranostics is rapidly evolving, with ongoing research focused on identifying new biomarkers, developing novel diagnostic tests, and discovering new targeted therapies.
False or inaccurate results may result in delayed treatments
This article delves into the latest advancements in immunotherapy research and development, its various types, and how it's shaping the future of oncology and beyond.
Need a laboratory for cancer research? Today, the US National Science Foundation issued a Press Release that the New York University Tandon School of Engineering has created a new synthetic hybrid molecule that delivers a blow to breast cancer cells. The hybrid...
Best and easiest methods to distinguish diseases and tumor types Immunohistochemistry (IHC) is a technique used to diagnose, or even differentiate, different types of cancers or other diseases. This lab test uses fluorescently dyed antibodies to selectively test...
The Ames test is an assay used throughout the world using bacteria to detect chemical substances that are known to cause DNA damage resulting in gene mutations. Testing is performed on substances from chemicals to new drugs. If the test results a positive, the...
Researchers identify 16 metabolite compounds used to differentiate between women with and without early-stage ovarian cancer
Advances in cytokine testing are paving the way for more personalized and effective treatment plans.
On November 3, 2016, the U.S. Department of Health and Human Services released its 14th Report on Carcinogens, or RoC. This report includes 248 chemicals, agents, substances, viruses, etc, that are known to, or have reason to believe, cause cancer in humans. Five...
Advertisement
According to a 2024 report by Markets and Markets, the global laboratory...
Contract Laboratory and OUTSOURCE! bring to you Microbiology Week,...
Advertisement
Advertisement